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Summary 
To investigate the accuracy of the age-at-onset criterion in those who meet other DSM-5 ADHD 
criteria (N=138), using a prospective population cohort, we compared four different approaches 
to asking those at age 25 years when their symptoms started. Receiver Operating Characteristic 
curves showed variation between the approaches (χ(3)=8.99, p=0.03); all four showed low 
discrimination against symptoms that had been assessed when they were children (area under 
the curve 0.57-0.68). Asking adults to recall specific symptoms may be preferable to recalling at 
what age symptoms started. However limitations to retrospective recall add to debate on the 
validity of ADHD age-at-onset assessment. 
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Assessment of age-at-onset criterion for adult attention-deficit hyperactivity disorder  
One criterion required for a diagnosis of ADHD is symptom onset before age 12 years (1). When 
individuals first present to clinicians as adults, this requires retrospective recall of symptoms 
and likely limits accuracy (1, 2) due to both false-positives and false-negatives (3). Identifying 
the optimal method to assess ADHD age-at-onset is an important question for adult 
psychiatrists. We compared the accuracy of four different ways to assess ADHD age-at-onset in a 
prospective population cohort. We focus on those who met the other DSM-5 criteria for ADHD at 
age 25 years: at-least five inattentive or five hyperactive/impulsive symptoms plus impairment. 
 
Method 
We analysed data from the Avon Longitudinal Study of Parents and Children (ALSPAC) (4) 
which includes repeated assessments since pregnancy (see Supplementary Material). Ethical 
approval was obtained from the ALSPAC Law and Ethics Committee and Local Research Ethics 
Committees. Informed consent was obtained from participants following the recommendations 
of the ALSPAC Ethics and Law Committee at the time. 
138 (42% male) individuals met DSM-5 symptom and impairment criteria at age 25 with 
complete data on age-at-onset and ADHD symptoms assessed in childhood (see below). 
Age 25 assessment: DSM-5 symptom and impairment criteria were assessed using self-reports 
of the Barkley Adult ADHD Rating Scale (BAARS-IV)(5, 6). Parents also completed the BAARS-IV: 
these data were used for sensitivity analyses (see below).  
The BAARS-IV uses two sets of questions for age-at-onset – (a) specify age: individuals were 
asked to recall as precisely as possible at what age these problems (ADHD symptoms) began to 
occur (in years) and (b) rate behaviour between 7 and 12 years: individuals were asked to rate 
the frequency of 18 DSM-5 ADHD symptoms on a 4-point scale. 
We generated four retrospective definitions of ADHD age-at-onset before age 12 years: 
(i) Specified age that ADHD symptoms began to occur was before age 12 years. 
(ii) At-least one ADHD symptom was endorsed as having been clinically significant 
(occurring ‘often’ or ‘very often’ (6)) between 7 and 12 years. 
(iii) Several symptoms (at-least three) were endorsed as having been clinically significant 
between 7 and 12 years (DSM-5 requires ‘several’ inattentive or 
hyperactive/impulsive symptoms present prior to age 12 years (7)). 
(iv) At least six inattentive or six hyperactive/impulsive symptoms were endorsed as 
having been clinically significant between 7 and 12 years (DSM-5 symptom 
requirement for childhood ADHD (7)). 
ADHD symptoms assessed during childhood: these had been assessed when these adults were 
aged 7, 8, 9 and 12 years using the 5-item ADHD subscale of the Strengths and Difficulties 
Questionnaire (SDQ)(8) rated by parents, as children’s self-reports are unreliable (9). The SDQ 
is a screening questionnaire with symptoms in the past 6 months categorised as low (0-5), 
slightly raised (6-7) or high (8-10)(8). Individuals with slightly raised or high symptoms (≥6) at 
any of these ages were defined as having ADHD symptoms when assessed in childhood: this was 
used to test the accuracy of adult retrospective reports of age-at-onset. This broad definition 
was used given the DSM-5 requirement that ‘several’ symptoms present prior to age 12 years 
(7). 
Measures for sensitivity analyses: (a) ADHD assessed during childhood defined based on full 
ADHD diagnosis at age 7/10 years, measured using the parent-rated Development and Well-
Being Assessment (9) (described in the Supplementary Materials), (b) age 25 assessments of 
age-at-onset using the parent-rated BAARS-IV.  
Analyses: Receiver Operating Characteristic (ROC) curve analyses using Stata’s roccomp 
function were used to examine the validity of the four retrospective assessments of ADHD age-
at-onset in distinguishing those with versus those without ADHD symptoms when assessed in 
childhood. 
 
Results 
Of those who met DSM-5 criteria for adult ADHD symptoms and impairment (N=138) at age 25, 
when asked to specify the age at which symptoms onset 51% (N=71) reported onset before age 
12 years. When asked to rate behaviour between 7 and 12 years, 86% (N=119) retrospectively 
reported at-least one ADHD symptom, 72% (N=100) reported at-least three symptoms and 44% 
(N=61) retrospectively reported six inattentive and/or six hyperactive/impulsive symptoms.  
Results for the four ADHD age-at-onset assessments are shown in Table 1. All approaches 
showed low discrimination in identifying ADHD symptoms assessed in childhood (AUC=0.57-
0.68), although there was evidence that this varied across the four approaches (χ(3)=8.99, 
p=0.03). 
Reporting at-least one symptom showed the highest sensitivity (the proportion of those with 
symptoms when assessed in childhood correctly identified by retrospective reports) and 
negative predictive validity (NPV: the proportion of those retrospectively reported not to have 
childhood-onset correctly identified) and the lowest specificity (the proportion of those without 
symptoms when assessed in childhood correctly identified by retrospective reports) and 
positive predictive validity (PPV: the proportion of those retrospectively identified who did 
have symptoms when assessed in childhood). Conversely retrospectively endorsing at-least six 
inattentive or six hyperactive/impulsive childhood symptoms showed the highest specificity 
and PPV whereas specifying age showed the lowest sensitivity and NPV. 
 
Sensitivity analyses 
Sensitivity analyses where ADHD assessed in childhood was defined based on full diagnostic 
criteria are shown in Supplementary Table 1 (N=122): this showed a similar pattern of results 
although with somewhat higher discrimination (AUC=0.60-0.81: χ(3)=96.00, p=1x10-20). Parent 
retrospective reports of age-at-onset at age 25, shown in Supplementary Table 2 (N=47): this 
showed fairly low discrimination (AUC=0.63-0.70) with little evidence of variation across the 
four approaches (χ(3)=1.19, p=0.76).  
 
Discussion 
We found variation in the discrimination of four approaches to retrospectively assess ADHD 
age-at-onset at age 25 years; although all showed limited validity. This is consistent with a 
Brazilian birth-cohort findings (10). Of the four approaches, the highest proportion of 
participants met age-at-onset criteria when this was defined based on asking participants to 
retrospectively rate their behaviour between ages 7 and 12 years, and requiring the 
endorsement of at-least one of the 18 DSM ADHD symptoms: this definition (which does not fit 
with the DSM-5 requirement that ‘several’ symptoms present prior to age 12 years) resulted in 
the highest proportion of true positives (highest sensitivity) but also the fewest true negatives. 
Conversely the highest specificity (and lowest proportion of people identified) was found using 
the most stringent definition: the retrospective endorsement of at-least six inattentive and/or 
six hyperactive/impulsive childhood symptoms. 
The alternative approach of asking participants to specify the age at which endorsed symptoms 
started resulted in the fewest true positives, i.e. this missed the most people who had ADHD 
symptoms when assessed in childhood. This provides tentative evidence that asking people to 
recall specific symptoms during a specific age period is preferable to recalling the age at which 
symptoms started. However none of the four approaches showed high accuracy, which is 
consistent with previous work highlighting the limitations of retrospective recall (3). Sensitivity 
analyses defining ADHD assessed in childhood based on full DSM-5 diagnostic criteria (and 
requiring the retrospective endorsement of six inattentive and/or six hyperactive/impulsive 
childhood symptoms) showed moderate discrimination. This suggests that recall of more severe 
and impairing symptoms may be better than for just a few symptoms. In practice there is likely 
benefit in asking about specific ADHD symptoms in childhood and acquiring additional 
information from other sources, e.g. school reports. 
While the age-at-onset criterion for ADHD is important from a developmental perspective (1), 
our results, alongside increasing evidence of “late-onset” ADHD (2), raise queries about its 
validity. Further research is needed to address the limitations of the current work, including 
limited sample size and non-random attrition. Defining age-at-onset is important for informing 
adult psychiatrists and diagnostic criteria. 
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Table 1. Discrimination of retrospective assessments of ADHD age-at-onset criterion in 
distinguishing those with and without ADHD symptoms when assessed in childhood, in young-
adults with ADHD symptoms and impairment at age 25 years 
 ROC AUC  
(95% CI) 
Accuracy Sensitivity Specificity PPV NPV 
Specified age 0.60 (0.52-0.69) 60% 63% 58% 55% 66% 
At-least one symptom 0.57 (0.51-0.62) 53% 94% 20% 49% 79% 
At least three (several) symptoms 0.62 (0.55-0.69) 59% 76% 53% 53% 76% 
Six inattentive and/or six 
hyperactive/impulsive symptoms 
0.68 (0.61-0.76) 69% 65% 72% 66% 71% 
ROC = Receiver Operating Characteristic, AUC = area under the curve, PPV = positive predictive 
values, NPV = negative predictive values. 
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